Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation
Genes · 26.01.2025 · 16 (2) · 160
DOI: 10.3390/genes16020160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 26.01.2025. Verfasst von Yang Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Sciences and Medicine, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background/Objectives: The heterogeneity of the tumor immune microenvironment is a key determinant of tumor oncogenesis. This study aims to evaluate the composition of seven immune cells across 5323 samples from 14 cancers using DNA methylation data.
Methods
A deconvolution algorithm was proposed to estimate the composition of seven immune cells using 1256 immune cell population-specific methylation genes. Based on the immune infiltration features of seven immune cell fractions, 42 subtypes of 14 tumors (2–5 subtypes per tumor) were identified.
Results
Significant differences in immune cells between subtypes were revealed for each cancer. The study found that the methylation values of the selected specific sites correlated with gene expression in most tumor subtypes. Immune infiltration results were integrated with phenotypic data, including survival data and tumor stages, revealing significant correlations between immune infiltration and phenotypes in some tumors. Subtypes with high proportions of CD4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ B cells, CD14+ monocytes, neutrophils, and eosinophils were identified, with subtype counts of 9, 24, 22, 13, 19, 9, and 11, respectively. Additionally, 2412 differentially expressed genes between these subtypes and normal tissues were identified. Pathway enrichment analysis revealed that these genes were mainly enriched in pathways related to drug response and chemical carcinogens. Differences in ESTIMATE scores for subtypes of seven tumors and TIDE scores for eight tumors were also observed.
Conclusions
This study demonstrates the intra-tumor and inter-tumor immune heterogeneity of pan-cancer through DNA methylation analysis, providing assistance for tumor diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Life Sciences and Medicine, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China.
- College of Pathology, Qiqihar Medical University, Qiqihar 161042, China.
ORCID-Profile: Yan Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Y., Liu, J., Shi, B., Ma, T., Yu, P., Li, J., Gu, Y., & Zhang, Y. (2025). Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation. Genes, 16(2), 160. https://doi.org/10.3390/genes16020160
Vancouver
Zhou Y, Liu J, Shi B, Ma T, Yu P, Li J, et al. Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation. Genes. 2025;16(2):160. doi:10.3390/genes16020160
BibTeX
@article{Zhou2025,
author = {Zhou, Yang and Liu, Jiebiao and Shi, Bowen and Ma, Te and Yu, Peishen and Li, Ji and Gu, Yue and Zhang, Yan},
title = {Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation},
journal = {Genes},
year = {2025},
volume = {16},
number = {2},
pages = {160},
doi = {10.3390/genes16020160}
}
EUVIMED